Prelude Therapeutics(PRLD) - 2025 Q3 - Earnings Call Transcript

Prelude Therapeutics (NasdaqGS:PRLD) Q3 2025 Earnings Call November 12, 2025 08:00 AM ET Speaker3Morning, everyone, and welcome everyone to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now turn the call over to Prelude's Chief Financial Officer and Chief Legal Officer, Bryant Lim. Please go ahead.Speaker0Thank you, Operator. During today's call, we will make forward-looking statements based on current expecta ...